| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028717 |
| Receipt No. | R000032868 |
| Official scientific title of the study | A study for evaluating the effects of oral intake of food originated from a microorganism on fatigue and immune functions. A randomized, double-blind, placebo- controlled trial. |
| Date of disclosure of the study information | 2018/06/01 |
| Last modified on | 2017/12/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A study for evaluating the effects of oral intake of food originated from a microorganism on fatigue and immune functions. A randomized, double-blind, placebo- controlled trial. | |
| Title of the study (Brief title) | A study for evaluating the effects of oral intake of food originated from a microorganism on fatigue and immune functions. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effects of oral intake of food originated from a microorganism on fatigue and immune functions. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Fatigue and stress indices (subjective indices) |
| Key secondary outcomes | Fatigue and stress indices (objective indices), immune indices (subjective indices) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Food originated from a microorganism, 1 portion of food per day for 14 days. | |
| Interventions/Control_2 | Placebo food, 1 portion of food per day for 14 days. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Healthy individuals aged more than 18 years old, when giving the informed consent.
2)Individuals who are received enough explanation of the purpose and the details of this study, who decided to attend this study with their own will, who have ability of agreement, and who submitted the informed consents in writing. |
|||
| Key exclusion criteria | 1)Individuals who have a medical history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder.
2)Individuals who have chronic diseases and use medicines continuously. 3)Individuals who need the application of medicine containing steroids. 4)Individuals who are seropositive against HBV antigen, HCV antibody, HIV antibody, or HTLV-1 antibody. 5)Individuals who cannot stop eating foods containing ingredients similar to test foods. 6)Individuals who cannot stop eating functional foods which may affect immune functions. 7)Individuals with excessive alcohol-drinking behaviors. 8)Individuals who cannot stop drinking for 2 days before the days of checkup. 9)Individuals who have a medical history of diseases affecting digestion and absorption. 10)Individuals who have a history of inflammatory bowel disease and irritable bowel syndrome. 11)Individuals who are judged as unsuitable for this study based on the results of blood test. 12)Individuals who have under treatment or a history of drug addiction and/or alcoholism. 13)Individuals who are participating or willing to participate in other clinical trials. 14)Individuals whose family works for a company manufacturing or selling healthy foods or functional foods. 15)Individuals who cannot sleep at night due to the irregular work-shift or other reasons. 16)Individuals who are judged unsuitable for this study by the investigator for other reasons. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kosuke Fukao |
| Organization | Juntendo University School of Health and Sports Science |
| Division name | Department of Sports Medicine (internal medicine) |
| Address | 1-1 Hirakagakuendai, Inzai, Chiba, Japan |
| TEL | 0476-98-1001 |
| fukao777@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Kosuke Fukao |
| Organization | Juntendo University School of Health and Sports Science |
| Division name | Department of Sports Medicine (internal medicine) |
| Address | 1-1 Hirakagakuendai, Inzai, Chiba, Japan |
| TEL | 0476-98-1001 |
| Homepage URL | |
| fukao777@juntendo.ac.jp | |
| Sponsor | |
| Institute | Department of Sports Medicine (internal medicine), Juntendo University School of Health and Sports Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kirin Company, Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 順天堂大学スポーツ健康科学部/Juntendo University School of Health and Sports Science |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032868 |